Senior researchers shun domestic pharmaceutical industry

Published: 2003-06-19 06:57:00

Updated: 2003-06-19 06:57:00

Pharmaceutical business sources say that the increasing exodus trend of senior researchers working in domestic pharmaceutical firms will put a wet blanket on the long-term development of the industry.

This unfavorable situation is noticeably prominent in those researchers in their 40s, who fee...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK